CFLAR and neoplasm: Data shown in Figure 6F demonstrate that protein synthesis was reduced in tumor cells treated with simvastatin and restored in the presence of mevalonate (Figure 6F), which closely correlated with the regulation of FLIP levels in these cells by the mevalonate pathway.